Table 9.
Additional ADMET Properties of 47, 49, 58, and 62a
47 | 49 | 58 | 62 | ||
---|---|---|---|---|---|
Plasma protein binding (% bound) |
human | 92.4 | 94.8 | 93.4 | 97.3 |
rat | ND | 94.3 | 91.5 | ND | |
dog | ND | 96.3 | 91.5 | ND | |
Binding in rat brain homogenate (2μM) (% bound) | ND | ND | 98.4 | ND | |
MDCK-MDR1 cell line (P-gp) | A-B (10−6 cm/s) | 8.76 | 13.5 | 7.1 | 4.6 |
Efflux ratio | 1.5 | 0.896 | 2.3 | 5.2 | |
Caco-2 cell line | A-B (10−6 cm/s) | 19.2 | ND | 20.9 | ND |
Efflux ratio | 0.493 | ND | 0.38 | ND | |
Solubility (μM) at pH 7.4 | 75 | 84 | 74 | 70 |
KOR-antagonists were used as monotartrate salts. ND = No data. A-B = movement of the compound from the apical to the basal side of the membrane; a surrogate for permeability.